Prot# 02-01-L: An Open-Label, Randomized, Prospective Multicenter Study to Compare Efficacy & Safety Among 3 Immunosuppressant Treatment Regimens in Patients Receiving a Liver Transplant for End-Stage Liver Disease Caused by Chronic Hepatitis C Infection

Project: Research project

Project Details

StatusFinished
Effective start/end date1/30/048/30/06

Funding

  • Baylor College of Medicine (02-01-L)
  • Roche Laboratories Inc. (02-01-L)